MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023
– Safety Profile Observed to Date as Monotherapy and in Combination with Venetoclax Suggests no Overlapping Toxicity – – Initial Results from Correlative Studies Demonstrate On-target...
United States Matthews Davids Davidm Urso American Society Of Hematology Harvard Medical School Pharma Inc
Source: marketscreener.com